Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 457

1.

Glycosphingolipid metabolic reprogramming drives neural differentiation.

Russo D, Della Ragione F, Rizzo R, Sugiyama E, Scalabrì F, Hori K, Capasso S, Sticco L, Fioriniello S, De Gregorio R, Granata I, Guarracino MR, Maglione V, Johannes L, Bellenchi GC, Hoshino M, Setou M, D'Esposito M, Luini A, D'Angelo G.

EMBO J. 2017 Dec 27. pii: e97674. doi: 10.15252/embj.201797674. [Epub ahead of print]

PMID:
29282205
2.

Differential protein modulation by ketoprofen and ibuprofen underlines different cellular response by gastric epithelium.

Brandolini L, d'Angelo M, Antonosante A, Villa S, Cristiano L, Castelli V, Benedetti E, Catanesi M, Aramini A, Luini A, Parashuraman S, Mayo E, Giordano A, Cimini A, Allegretti M.

J Cell Physiol. 2018 Mar;233(3):2304-2312. doi: 10.1002/jcp.26102. Epub 2017 Aug 25.

PMID:
28710861
3.

Robotic Nipple-sparing Mastectomy and Immediate Breast Reconstruction With Implant: First Report of Surgical Technique.

Toesca A, Peradze N, Galimberti V, Manconi A, Intra M, Gentilini O, Sances D, Negri D, Veronesi G, Rietjens M, Zurrida S, Luini A, Veronesi U, Veronesi P.

Ann Surg. 2017 Aug;266(2):e28-e30. doi: 10.1097/SLA.0000000000001397. No abstract available.

PMID:
28692558
4.

The Veronesi quadrantectomy: an historical overview.

Corso G, Veronesi P, Sacchini V, Galimberti V, Luini A.

Ecancermedicalscience. 2017 Jun 8;11:743. doi: 10.3332/ecancer.2017.743. eCollection 2017.

5.

Sphingolipid metabolic flow controls phosphoinositide turnover at the trans-Golgi network.

Capasso S, Sticco L, Rizzo R, Pirozzi M, Russo D, Dathan NA, Campelo F, van Galen J, Hölttä-Vuori M, Turacchio G, Hausser A, Malhotra V, Riezman I, Riezman H, Ikonen E, Luberto C, Parashuraman S, Luini A, D'Angelo G.

EMBO J. 2017 Jun 14;36(12):1736-1754. doi: 10.15252/embj.201696048. Epub 2017 May 10.

PMID:
28495678
6.

On the role of Mitofusin 2 in endoplasmic reticulum-mitochondria tethering.

Filadi R, Greotti E, Turacchio G, Luini A, Pozzan T, Pizzo P.

Proc Natl Acad Sci U S A. 2017 Mar 21;114(12):E2266-E2267. doi: 10.1073/pnas.1616040114. Epub 2017 Mar 13. No abstract available.

7.

Rare ER protein misfolding-mistrafficking disorders: Therapeutic developments.

Hegde RN, Subramanian A, Pothukuchi P, Parashuraman S, Luini A.

Tissue Cell. 2017 Apr;49(2 Pt A):175-185. doi: 10.1016/j.tice.2017.02.001. Epub 2017 Feb 9. Review.

PMID:
28222887
8.

Characterization of human leukocyte-HUVEC adhesion: Effect of cell preparation methods.

Marino F, Schembri L, Rasini E, Pinoli M, Scanzano A, Luini A, Congiu T, Cosentino M.

J Immunol Methods. 2017 Apr;443:55-63. doi: 10.1016/j.jim.2017.01.013. Epub 2017 Feb 3.

PMID:
28167274
9.

Ipsilateral axillary recurrence after breast conservative surgery: The protective effect of whole breast radiotherapy.

Gentilini O, Botteri E, Leonardi MC, Rotmensz N, Vila J, Peradze N, Thomazini MV, Jereczek BA, Galimberti V, Luini A, Veronesi P, Orecchia R.

Radiother Oncol. 2017 Jan;122(1):37-44. doi: 10.1016/j.radonc.2016.12.021. Epub 2017 Jan 4.

PMID:
28063695
10.

Supernumerary Axillary Breast Cancer.

Soto S, Toesca A, Hamza A, Della Corte GA, Iera M, Peradze N, Rocco N, Enrica GV, Bonanni B, Corso G, Luini A, Rietjens M, De Lorenzi F, Veronesi P, Martella S.

Breast J. 2017 Mar;23(2):246-248. doi: 10.1111/tbj.12724. Epub 2016 Oct 31. No abstract available.

PMID:
27797134
11.

Reversible Controlled Aggregation of Golgi Resident Enzymes to Assess Their Transport/Dynamics Along the Secretory Pathway.

Rizzo R, Luini A.

Methods Mol Biol. 2016;1496:163-72. doi: 10.1007/978-1-4939-6463-5_13.

PMID:
27632009
12.

Divergent in vitro/in vivo responses to drug treatments of highly aggressive NIH-Ras cancer cells: a PET imaging and metabolomics-mass-spectrometry study.

Gaglio D, Valtorta S, Ripamonti M, Bonanomi M, Damiani C, Todde S, Negri AS, Sanvito F, Mastroianni F, Di Campli A, Turacchio G, Di Grigoli G, Belloli S, Luini A, Gilardi MC, Colangelo AM, Alberghina L, Moresco RM.

Oncotarget. 2016 Aug 9;7(32):52017-52031. doi: 10.18632/oncotarget.10470.

13.

Golgi membrane fission requires the CtBP1-S/BARS-induced activation of lysophosphatidic acid acyltransferase δ.

Pagliuso A, Valente C, Giordano LL, Filograna A, Li G, Circolo D, Turacchio G, Marzullo VM, Mandrich L, Zhukovsky MA, Formiggini F, Polishchuk RS, Corda D, Luini A.

Nat Commun. 2016 Jul 12;7:12148. doi: 10.1038/ncomms12148.

14.

GOLPH3 and oncogenesis: What is the molecular link?

Rizzo R, Parashuraman S, D'Angelo G, Luini A.

Tissue Cell. 2017 Apr;49(2 Pt A):170-174. doi: 10.1016/j.tice.2016.06.008. Epub 2016 Jun 17. Review.

PMID:
27378035
15.

Presenilin 2 Modulates Endoplasmic Reticulum-Mitochondria Coupling by Tuning the Antagonistic Effect of Mitofusin 2.

Filadi R, Greotti E, Turacchio G, Luini A, Pozzan T, Pizzo P.

Cell Rep. 2016 Jun 7;15(10):2226-2238. doi: 10.1016/j.celrep.2016.05.013. Epub 2016 May 26.

16.

Signaling at the Golgi: sensing and controlling the membrane fluxes.

Luini A, Parashuraman S.

Curr Opin Cell Biol. 2016 Apr;39:37-42. doi: 10.1016/j.ceb.2016.01.014. Epub 2016 Feb 22. Review.

PMID:
26908115
17.

Physical function of the upper limb after breast cancer surgery. Results from the SOUND (Sentinel node vs. Observation after axillary Ultra-souND) trial.

Gentilini O, Botteri E, Dadda P, Sangalli C, Boccardo C, Peradze N, Ghisini R, Galimberti V, Veronesi P, Luini A, Cassano E, Viale G, Veronesi U.

Eur J Surg Oncol. 2016 May;42(5):685-9. doi: 10.1016/j.ejso.2016.01.020. Epub 2016 Feb 3.

PMID:
26899941
18.

Sentinel node biopsy after neoadjuvant treatment in breast cancer: Five-year follow-up of patients with clinically node-negative or node-positive disease before treatment.

Galimberti V, Ribeiro Fontana SK, Maisonneuve P, Steccanella F, Vento AR, Intra M, Naninato P, Caldarella P, Iorfida M, Colleoni M, Viale G, Grana CM, Rotmensz N, Luini A.

Eur J Surg Oncol. 2016 Mar;42(3):361-8. doi: 10.1016/j.ejso.2015.11.019. Epub 2015 Dec 25.

PMID:
26746091
19.

Unravelling druggable signalling networks that control F508del-CFTR proteostasis.

Hegde RN, Parashuraman S, Iorio F, Ciciriello F, Capuani F, Carissimo A, Carrella D, Belcastro V, Subramanian A, Bounti L, Persico M, Carlile G, Galietta L, Thomas DY, Di Bernardo D, Luini A.

Elife. 2015 Dec 23;4. pii: e10365. doi: 10.7554/eLife.10365.

20.

Identification of p38 MAPK and JNK as new targets for correction of Wilson disease-causing ATP7B mutants.

Chesi G, Hegde RN, Iacobacci S, Concilli M, Parashuraman S, Festa BP, Polishchuk EV, Di Tullio G, Carissimo A, Montefusco S, Canetti D, Monti M, Amoresano A, Pucci P, van de Sluis B, Lutsenko S, Luini A, Polishchuk RS.

Hepatology. 2016 Jun;63(6):1842-59. doi: 10.1002/hep.28398. Epub 2016 Jan 25.

Supplemental Content

Loading ...
Support Center